Kjersti Jørgensen

535 total citations
9 papers, 419 citations indexed

About

Kjersti Jørgensen is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Kjersti Jørgensen has authored 9 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Genetics. Recurrent topics in Kjersti Jørgensen's work include Melanoma and MAPK Pathways (3 papers), Ubiquitin and proteasome pathways (2 papers) and BRCA gene mutations in cancer (2 papers). Kjersti Jørgensen is often cited by papers focused on Melanoma and MAPK Pathways (3 papers), Ubiquitin and proteasome pathways (2 papers) and BRCA gene mutations in cancer (2 papers). Kjersti Jørgensen collaborates with scholars based in Norway. Kjersti Jørgensen's co-authors include Aage Haugen, Steen Mollerup, G Berge, Viví Ann Flørenes, Martina L. Skrede, Ben Davidson, Ana Slipicevic, Jahn M. Nesland, Ruth Holm and Gunhild M. Mælandsmo and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Modern Pathology and BMC Cancer.

In The Last Decade

Kjersti Jørgensen

9 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kjersti Jørgensen Norway 8 233 174 114 109 79 9 419
Lora Bagryanova United States 9 203 0.9× 144 0.8× 79 0.7× 141 1.3× 71 0.9× 9 380
Pontus Berglund Sweden 9 171 0.7× 148 0.9× 132 1.2× 49 0.4× 71 0.9× 15 414
Jessica M. Bennett United States 11 160 0.7× 214 1.2× 161 1.4× 35 0.3× 48 0.6× 13 409
Rachel Ruoff United States 12 228 1.0× 71 0.4× 47 0.4× 111 1.0× 61 0.8× 15 336
Jade Peres South Africa 13 308 1.3× 112 0.6× 51 0.4× 61 0.6× 104 1.3× 20 456
Ilianna Zoi Greece 8 125 0.5× 115 0.7× 87 0.8× 59 0.5× 69 0.9× 10 262
Alexander C. Jordan United States 7 307 1.3× 134 0.8× 38 0.3× 60 0.6× 87 1.1× 10 453
Caroline Miller United States 7 228 1.0× 178 1.0× 65 0.6× 40 0.4× 141 1.8× 9 434
Katharine Van Horn United States 8 397 1.7× 260 1.5× 214 1.9× 87 0.8× 65 0.8× 9 639
Ielizaveta Gorodetska Germany 8 200 0.9× 122 0.7× 80 0.7× 78 0.7× 101 1.3× 13 333

Countries citing papers authored by Kjersti Jørgensen

Since Specialization
Citations

This map shows the geographic impact of Kjersti Jørgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kjersti Jørgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kjersti Jørgensen more than expected).

Fields of papers citing papers by Kjersti Jørgensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kjersti Jørgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kjersti Jørgensen. The network helps show where Kjersti Jørgensen may publish in the future.

Co-authorship network of co-authors of Kjersti Jørgensen

This figure shows the co-authorship network connecting the top 25 collaborators of Kjersti Jørgensen. A scholar is included among the top collaborators of Kjersti Jørgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kjersti Jørgensen. Kjersti Jørgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gravdehaug, Berit, Hilde Lurås, Ellen Schlichting, et al.. (2022). “It was an important part of my treatment”: a qualitative study of Norwegian breast Cancer patients’ experiences with mainstreamed genetic testing. Hereditary Cancer in Clinical Practice. 20(1). 6–6. 7 indexed citations
2.
Grindedal, Eli Marie, Kjersti Jørgensen, Berit Gravdehaug, et al.. (2020). Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway. Familial Cancer. 19(2). 133–142. 19 indexed citations
3.
Berland, Siren, et al.. (2020). Birt-Hogg-Dubé-syndrom. Tidsskrift for Den norske legeforening. 140(6). 2 indexed citations
4.
Slipicevic, Ana, Kjersti Jørgensen, Martina L. Skrede, et al.. (2008). The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells. BMC Cancer. 8(1). 276–276. 61 indexed citations
5.
Jørgensen, Kjersti, Ben Davidson, & Viví Ann Flørenes. (2006). Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma. Modern Pathology. 19(11). 1446–1455. 31 indexed citations
6.
Jørgensen, Kjersti, Martina L. Skrede, Véronique Cruciani, et al.. (2005). Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2. Biochemical and Biophysical Research Communications. 329(1). 266–274. 27 indexed citations
7.
Flørenes, Viví Ann, Martina L. Skrede, Kjersti Jørgensen, & Jahn M. Nesland. (2004). Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival. Melanoma Research. 14(3). 173–181. 46 indexed citations
8.
Jørgensen, Kjersti, Ruth Holm, Gunhild M. Mælandsmo, & Viví Ann Flørenes. (2003). Expression of activated extracellular signal-regulated kinases 1/2 in malignant melanomas: relationship with clinical outcome.. PubMed. 9(14). 5325–31. 39 indexed citations
9.
Mollerup, Steen, Kjersti Jørgensen, G Berge, & Aage Haugen. (2002). Expression of estrogen receptors α and β in human lung tissue and cell lines. Lung Cancer. 37(2). 153–159. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026